HEPA

Hepion Pharmaceuticals

Delisted

HEPA was delisted on the 12th of May, 2025.

4 hedge funds and large institutions have $1.3M invested in Hepion Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$596K
HighTower Advisors
2
HighTower Advisors
Illinois
$244K
Barclays
3
Barclays
United Kingdom
$125K
Geode Capital Management
4
Geode Capital Management
Massachusetts
$72K
JPMorgan Chase & Co
5
JPMorgan Chase & Co
New York
$46K -$72K
PFS
6
Prospera Financial Services
Texas
$38K -$57K
CS
7
Credit Suisse
Switzerland
$35K -$54K
Citadel Advisors
8
Citadel Advisors
Florida
$31K -$52K
Northern Trust
9
Northern Trust
Illinois
$26K -$39K
Morgan Stanley
10
Morgan Stanley
New York
$15K -$26K
PAG
11
Private Advisor Group
New Jersey
$14K
Bank of Montreal
12
Bank of Montreal
Ontario, Canada
$12K -$18K
BlackRock
13
BlackRock
New York
$11K -$22K
Bank of New York Mellon
14
Bank of New York Mellon
New York
$9K -$13K
TSS
15
Two Sigma Securities
New York
$8K -$26K
LPL Financial
16
LPL Financial
California
$4K -$5K
RJFSA
17
Raymond James Financial Services Advisors
Florida
$4K
USAA
18
United Services Automobile Association
Texas
$4K
UBS Group
19
UBS Group
Switzerland
$2K -$4K
VF
20
Virtu Financial
New York
$2K -$65K
BWA
21
BDO Wealth Advisors
Florida
$1K -$1K
Wells Fargo
22
Wells Fargo
California
$1K -$1K
IWM
23
IHT Wealth Management
Illinois
$1K -$2K
AFM
24
Anson Funds Management
Texas
-$446K -2 Closed
FFA
25
First Foundation Advisors
California
-$4K